Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance Imaging

Jean-Philippe Galons, Maria I Altbach, Gillian D. Paine-Murrieta, Charles W. Taylor, Robert J. Gillies

Research output: Contribution to journalArticle

160 Citations (Scopus)

Abstract

An important goal in cancer chemotherapy is to sensitively and quantitatively monitor the response of individual patients' tumors to successful, or unsuccessful, therapy so that regimens can be altered iteratively. Currently, tumor response is monitored by frank changes in tumor morphology, yet these markers take long to manifest and are not quantitative. Recent studies suggest that the apparent diffusion coefficient of water (ADCw), measured noninvasively with magnetic resonance imaging, is sensitively and reliably increased in response to successful CTx. In the present study, we investigate the combination chemotherapy response of human breast cancer tumor xenografts sensitive or resistant to Paclitaxel by monitoring changes in the ADCw. Our results indicate that there is a clear, substantial, and early increase in the ADCw after successful therapy in drug sensitive tumors and that there is no change in the ADCw in p-glycoprotein-positive tumors, which are resistant to Paclitaxel. The mechanism underlying these changes is unknown yet is consistent with apoptotic cell shrinkage and a concomitant increase in the extracellular water fraction.

Original languageEnglish (US)
Pages (from-to)113-117
Number of pages5
JournalNeoplasia
Volume1
Issue number2
StatePublished - Jun 1999

Fingerprint

Diffusion Magnetic Resonance Imaging
Paclitaxel
Heterografts
Breast Neoplasms
Water
Neoplasms
Therapeutics
Drug Therapy
Combination Drug Therapy
Glycoproteins
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Cancer Research

Cite this

Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance Imaging. / Galons, Jean-Philippe; Altbach, Maria I; Paine-Murrieta, Gillian D.; Taylor, Charles W.; Gillies, Robert J.

In: Neoplasia, Vol. 1, No. 2, 06.1999, p. 113-117.

Research output: Contribution to journalArticle

@article{9979a87f7a9446ef8f0f3d547485ee65,
title = "Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance Imaging",
abstract = "An important goal in cancer chemotherapy is to sensitively and quantitatively monitor the response of individual patients' tumors to successful, or unsuccessful, therapy so that regimens can be altered iteratively. Currently, tumor response is monitored by frank changes in tumor morphology, yet these markers take long to manifest and are not quantitative. Recent studies suggest that the apparent diffusion coefficient of water (ADCw), measured noninvasively with magnetic resonance imaging, is sensitively and reliably increased in response to successful CTx. In the present study, we investigate the combination chemotherapy response of human breast cancer tumor xenografts sensitive or resistant to Paclitaxel by monitoring changes in the ADCw. Our results indicate that there is a clear, substantial, and early increase in the ADCw after successful therapy in drug sensitive tumors and that there is no change in the ADCw in p-glycoprotein-positive tumors, which are resistant to Paclitaxel. The mechanism underlying these changes is unknown yet is consistent with apoptotic cell shrinkage and a concomitant increase in the extracellular water fraction.",
author = "Jean-Philippe Galons and Altbach, {Maria I} and Paine-Murrieta, {Gillian D.} and Taylor, {Charles W.} and Gillies, {Robert J.}",
year = "1999",
month = "6",
language = "English (US)",
volume = "1",
pages = "113--117",
journal = "Neoplasia",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance Imaging

AU - Galons, Jean-Philippe

AU - Altbach, Maria I

AU - Paine-Murrieta, Gillian D.

AU - Taylor, Charles W.

AU - Gillies, Robert J.

PY - 1999/6

Y1 - 1999/6

N2 - An important goal in cancer chemotherapy is to sensitively and quantitatively monitor the response of individual patients' tumors to successful, or unsuccessful, therapy so that regimens can be altered iteratively. Currently, tumor response is monitored by frank changes in tumor morphology, yet these markers take long to manifest and are not quantitative. Recent studies suggest that the apparent diffusion coefficient of water (ADCw), measured noninvasively with magnetic resonance imaging, is sensitively and reliably increased in response to successful CTx. In the present study, we investigate the combination chemotherapy response of human breast cancer tumor xenografts sensitive or resistant to Paclitaxel by monitoring changes in the ADCw. Our results indicate that there is a clear, substantial, and early increase in the ADCw after successful therapy in drug sensitive tumors and that there is no change in the ADCw in p-glycoprotein-positive tumors, which are resistant to Paclitaxel. The mechanism underlying these changes is unknown yet is consistent with apoptotic cell shrinkage and a concomitant increase in the extracellular water fraction.

AB - An important goal in cancer chemotherapy is to sensitively and quantitatively monitor the response of individual patients' tumors to successful, or unsuccessful, therapy so that regimens can be altered iteratively. Currently, tumor response is monitored by frank changes in tumor morphology, yet these markers take long to manifest and are not quantitative. Recent studies suggest that the apparent diffusion coefficient of water (ADCw), measured noninvasively with magnetic resonance imaging, is sensitively and reliably increased in response to successful CTx. In the present study, we investigate the combination chemotherapy response of human breast cancer tumor xenografts sensitive or resistant to Paclitaxel by monitoring changes in the ADCw. Our results indicate that there is a clear, substantial, and early increase in the ADCw after successful therapy in drug sensitive tumors and that there is no change in the ADCw in p-glycoprotein-positive tumors, which are resistant to Paclitaxel. The mechanism underlying these changes is unknown yet is consistent with apoptotic cell shrinkage and a concomitant increase in the extracellular water fraction.

UR - http://www.scopus.com/inward/record.url?scp=0033140111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033140111&partnerID=8YFLogxK

M3 - Article

C2 - 10933044

AN - SCOPUS:0033140111

VL - 1

SP - 113

EP - 117

JO - Neoplasia

JF - Neoplasia

SN - 1522-8002

IS - 2

ER -